Table 5.
Ranks | Title | Journal | Co-citation | Centrailty | Ref |
---|---|---|---|---|---|
1 | Stem cell therapy for liver disease: Parameters governing the success of using bone marrow mesenchymal stem cells | Gastroenterology | 79 | 0.06 | 35 |
2 | Autologous Bone Marrow Mesenchymal Stem Cell Transplantation in Liver Failure Patients Caused by Hepatitis B: Short-Term and Long-Term Outcomes | Hepatology | 72 | 0.09 | 36 |
3 | Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers | Gut | 72 | 0.08 | 37 |
4 | Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo | Hepatology | 71 | 0.04 | 38 |
5 | Transplantation With Autologous Bone Marrow-Derived Mesenchymal Stem Cells for Alcoholic Cirrhosis: Phase 2 Trial | Hepatology | 69 | 0.06 | 39 |
6 | In vitro hepatic differentiation of human mesenchymal stem cells | Hepatology | 66 | 0.01 | 7 |
7 | Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion | Blood | 60 | 0.01 | 40 |
8 | Concise Review: Therapeutic Potential of Mesenchymal Stem Cells for the Treatment of Acute Liver Failure and Cirrhosis | Stem cells | 59 | 0.05 | 41 |
9 | Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo | Gut | 58 | 0.02 | 8 |
10 | Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure: A Randomized Controlled Trial | Hepatology | 56 | 0.02 | 42 |